In vitro assessment of pesticides capacity to act as agonists/antagonists of the thyroid hormone nuclear receptors

In vitro assessment of pesticides capacity to act as agonists/antagonists of the thyroid hormone nuclear receptors

Show other versions (1)

Bibliographic Details
Main Authors:	Yanis Zekri, Laure Dall Agnol, Frédéric Flamant, Romain Guyot
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	iScience
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589004221012153

Similar Items

In vitro assessment of pesticides capacity to act as agonists/antagonists of the thyroid hormone nuclear receptors
by: Yanis Zekri, et al.
Published: (2021-09-01)

An Atlas of Thyroid Hormone Receptors’ Target Genes in Mouse Tissues
by: Yanis Zekri, et al.
Published: (2022-09-01)

Central vs. Peripheral Action of Thyroid Hormone in Adaptive Thermogenesis: A Burning Topic
by: Yanis Zekri, et al.
Published: (2021-05-01)

Brown adipocytes local response to thyroid hormone is required for adaptive thermogenesis in adult male mice
by: Yanis Zekri, et al.
Published: (2022-11-01)

Genome-wide search reveals the existence of a limited number of thyroid hormone receptor alpha target genes in cerebellar neurons.
by: Fabrice Chatonnet, et al.
Published: (2012-01-01)

A Pivotal Genetic Program Controlled by Thyroid Hormone during the Maturation of GABAergic Neurons
by: Sabine Richard, et al.
Published: (2020-03-01)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Eun Jin Han, et al.
Published: (2013-09-01)

Thyroid hormones act as modulators of inflammation through their nuclear receptors
by: Marina Lasa, et al.
Published: (2022-08-01)

Thyroid hormone action during GABAergic neuron maturation: The quest for mechanisms
by: Sabine Richard, et al.
Published: (2023-10-01)

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
by: Ross C. Anderson, et al.
Published: (2019-01-01)

HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
by: K. M. Nyushko, et al.
Published: (2015-01-01)

Thyroid hormone and thyroid hormone nuclear receptors: History and present state of art
by: Brtko Julius
Published: (2021-04-01)

Lower odds of cardiac events for gonadotropic releasing hormone antagonists versus agonists
by: E.B. Cone, et al.
Published: (2020-07-01)

Thyroid Hormone Receptor Agonist Promotes Hair Growth in Mice
by: Zhu P, et al.
Published: (2022-02-01)

Increased Thyroid Hormone Levels in Pesticide Sprayer at Agricultural Area
by: Aditya Sukma Pawitra, et al.
Published: (2022-02-01)

An agonist–antagonist cerebellar nuclear system controlling eyelid kinematics during motor learning
by: Raudel eSánchez-Campusano, et al.
Published: (2012-03-01)

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonists the Same?
by: Marc Miravitlles, M.D., et al.
Published: (2018-07-01)

Acute Changes in Thyroid Hormone Levels among Thai Pesticide Sprayers
by: Pornpimol Kongtip, et al.
Published: (2021-01-01)

Pesticides Exposure and Thyroid Hormone Levels Among Agricultural Workers and Pesticide Applicators: A Systematic Review
by: Suratman Suratman, et al.
Published: (2022-07-01)

Muscarinic Receptor Agonists and Antagonists
by: David R. Kelly, et al.
Published: (2001-02-01)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
by: Wignall Jacqui, et al.
Published: (2010-04-01)

Structural Motif Descriptors as a Way To Elucidate the Agonistic or Antagonistic Activity of Growth Hormone–Releasing Hormone Peptide Analogues
by: Kevin Jeanne Dit Fouque, et al.
Published: (2018-07-01)

Correction: Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
Published: (2013-01-01)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
by: Chen Q, et al.
Published: (2019-05-01)

Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long-acting β2-agonists/long-acting muscarinic antagonists
by: Nevin Kishore, et al.
Published: (2020-01-01)

Synthesis of Analogues of Thyroid Hormones: Nuclear Receptor Modulators
by: Guilherme Vieira de Castro, et al.
Published: (2015-09-01)

Synthesis of Analogues of Thyroid Hormones: Nuclear Receptor Modulators
by: Guilherme Vieira de Castro, et al.
Published: (2015-09-01)

Pesticides With Potential Thyroid Hormone-Disrupting Effects: A Review of Recent Data
by: Michelle Leemans, et al.
Published: (2019-12-01)

Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity
by: Begum Aydogan Mathyk, et al.
Published: (2018-04-01)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
by: Eung Gu Lee, et al.
Published: (2023-05-01)

Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis
by: Israel Silva Maia, et al.

Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
by: Yamada H, et al.
Published: (2018-10-01)

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
by: Andrea Caddeo, et al.
Published: (2021-12-01)

Organophosphate pesticides exposure in pregnant women and maternal and cord blood thyroid hormone concentrations
by: Tessa A. Mulder, et al.
Published: (2019-11-01)

Genetic Polymorphisms of Pesticide-Metabolizing Enzymes and Transporters in Agricultural Workers and Thyroid Hormone Levels
by: Sirivarasai J, et al.
Published: (2021-08-01)

Comparisons of Different Dosages of Gonadotropin-Releasing Hormone (GnRH) Antagonist, Short-acting Form and Single, Half-dose, Long-acting Form of GnRH Agonist During Controlled Ovarian Hyperstimulation and in vitro Fertilization
by: Yao-Yuan Hsieh, et al.
Published: (2008-03-01)

Gonadotropin releasing hormone antagonist protocol brings about more available embryos than agonist long protocol
by: ZHAO Shan-ke, FU Yao, CHU Da-peng, FU Lei, HAN Shuo, BAI Xue-yan, LI Yuan, ZHOU Wen-hui
Published: (2022-03-01)

Retracted: Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Gonadotropin Releasing Hormone Agonists versus Antagonists in Women with Polycystic Ovary Disease Undergoing Intracytoplasmic Sperm Injection
by: Onder Sakin, et al.
Published: (2018-11-01)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
by: Behnaz Khani Rabati, et al.
Published: (2012-01-01)